MRNA stock pitch - 2021-08-16

Added to YB: 2021-08-16

Pitch date: 2021-08-16

Moderna, Inc.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Market Cap

$22.1B

Pitch Price

$361.00

Price Target

N/A

Dividend

N/A

EV/EBITDA

-5.56

P/E

-7.72

EV/Sales

7.86

Sector

Biotechnology

A summary for this pitch has not been created yet.